Cite Filings / SPRY / 0001972362-24-001856
Feed Companies Filings Check
Sign in
144

Sale of Securities

ARS Pharmaceuticals, Inc. · Filed 2024-12-12 · Acc 0001972362-24-001856

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2024-12-13 144 Sale of Securities
  • 2024-12-13 4 Chief Business Officer sold 144,605 shares at an average $12.23 ($1,768,093)
  • 2024-12-12 144 Sale of Securities
  • 2024-12-12 4 Chief Business Officer sold 50,000 shares at $13.15 ($657,625)
  • 2024-12-11 144 Sale of Securities
  • 2024-12-11 4 CHIEF MEDICAL OFFICER sold 100,000 shares at an average $13.16 ($1,316,420)
  • 2024-12-11 4 PRESIDENT AND CEO sold 100,000 shares at an average $13.16 ($1,316,420)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…